CooperCompanies announced its Q1 2021 financial results, with revenue up 5% year-over-year to $680.5 million. GAAP diluted earnings per share were $42.31, and non-GAAP diluted earnings per share were $3.17, an 18% increase from the previous year. The company initiated fiscal year 2021 guidance, expressing enthusiasm for future prospects.
Revenue increased by 5% year-over-year, reaching $680.5 million.
CooperVision (CVI) revenue increased by 4% to $507.0 million.
CooperSurgical (CSI) revenue increased by 8% to $173.5 million.
Non-GAAP diluted earnings per share increased by 18% to $3.17.
CooperCompanies provided fiscal year 2021 guidance, with total revenue expected to be between $2,800 and $2,845 million and non-GAAP diluted EPS between $12.90 and $13.10.
Visualization of income flow from segment revenue to net income